Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/JNJ-Q2> ?p ?o }
Showing triples 1 to 60 of
60
with 100 triples per page.
- JNJ-Q2 abstract "JNJ-Q2 is a broad-spectrum fluoroquinolone antibacterial drug being developed for the treatment of acute bacterial skin and skin-structure infections and community-acquired pneumonia. Specifically, JNJ-Q2 is being actively studied for treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections.Furiex Pharmaceuticals has licensed JNJ-Q2 from Janssen Pharmaceutica, a unit of Johnson & Johnson, which discovered JNJ-Q2. Furiex is responsible for its development and commercialization. Both oral and intravenous formulations are being developed.".
- JNJ-Q2 iupacName "7-[(3E)-3-(2-Amino-1-fluoroethylidene)-1-piperidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid".
- JNJ-Q2 thumbnail JNJ-Q2.svg?width=300.
- JNJ-Q2 wikiPageID "36867195".
- JNJ-Q2 wikiPageLength "3259".
- JNJ-Q2 wikiPageOutDegree "10".
- JNJ-Q2 wikiPageRevisionID "707384318".
- JNJ-Q2 wikiPageWikiLink Antibiotics.
- JNJ-Q2 wikiPageWikiLink Category:Cyclopropanes.
- JNJ-Q2 wikiPageWikiLink Category:Fluoroquinolone_antibiotics.
- JNJ-Q2 wikiPageWikiLink Category:Piperidines.
- JNJ-Q2 wikiPageWikiLink Janssen_Pharmaceutica.
- JNJ-Q2 wikiPageWikiLink Johnson_&_Johnson.
- JNJ-Q2 wikiPageWikiLink Methicillin-resistant_Staphylococcus_aureus.
- JNJ-Q2 wikiPageWikiLink Pneumonia.
- JNJ-Q2 wikiPageWikiLink Quinolone.
- JNJ-Q2 wikiPageWikiLink Skin.
- JNJ-Q2 wikiPageWikiLinkText "JNJ-Q2".
- JNJ-Q2 c "21".
- JNJ-Q2 chemspiderid "9721013".
- JNJ-Q2 f "2".
- JNJ-Q2 h "23".
- JNJ-Q2 iupacName "7".
- JNJ-Q2 molecularWeight "419.42".
- JNJ-Q2 n "3".
- JNJ-Q2 o "4".
- JNJ-Q2 routesOfAdministration "Oral, IV".
- JNJ-Q2 smiles "Fc1cN4C/CCCC4".
- JNJ-Q2 stdinchi "InChI=1S/C21H23F2N3O4/c1-30-20-17-137-151825-6-2-3-11168-24/h7,10,12H,2-6,8-9,24H2,1H3,/b16-11+".
- JNJ-Q2 stdinchikey "VMKVDAAFMQKZJS-LFIBNONCSA-N".
- JNJ-Q2 wikiPageUsesTemplate Template:Antibiotic-stub.
- JNJ-Q2 wikiPageUsesTemplate Template:Cascite.
- JNJ-Q2 wikiPageUsesTemplate Template:Chemspidercite.
- JNJ-Q2 wikiPageUsesTemplate Template:Drugbankcite.
- JNJ-Q2 wikiPageUsesTemplate Template:Drugbox.
- JNJ-Q2 wikiPageUsesTemplate Template:Fdacite.
- JNJ-Q2 wikiPageUsesTemplate Template:Keggcite.
- JNJ-Q2 wikiPageUsesTemplate Template:QuinoloneAntiBiotics.
- JNJ-Q2 wikiPageUsesTemplate Template:Reflist.
- JNJ-Q2 wikiPageUsesTemplate Template:Stdinchicite.
- JNJ-Q2 subject Category:Cyclopropanes.
- JNJ-Q2 subject Category:Fluoroquinolone_antibiotics.
- JNJ-Q2 subject Category:Piperidines.
- JNJ-Q2 hypernym Drug.
- JNJ-Q2 type ChemicalSubstance.
- JNJ-Q2 type Drug.
- JNJ-Q2 type Chemical.
- JNJ-Q2 type ChemicalObject.
- JNJ-Q2 type Thing.
- JNJ-Q2 type Q8386.
- JNJ-Q2 comment "JNJ-Q2 is a broad-spectrum fluoroquinolone antibacterial drug being developed for the treatment of acute bacterial skin and skin-structure infections and community-acquired pneumonia. Specifically, JNJ-Q2 is being actively studied for treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections.Furiex Pharmaceuticals has licensed JNJ-Q2 from Janssen Pharmaceutica, a unit of Johnson & Johnson, which discovered JNJ-Q2.".
- JNJ-Q2 label "JNJ-Q2".
- JNJ-Q2 sameAs Q6108575.
- JNJ-Q2 sameAs m.0lqhs0l.
- JNJ-Q2 sameAs JNJ-Q2.
- JNJ-Q2 sameAs JNJ-Q2.
- JNJ-Q2 sameAs Q6108575.
- JNJ-Q2 wasDerivedFrom JNJ-Q2?oldid=707384318.
- JNJ-Q2 depiction JNJ-Q2.svg.
- JNJ-Q2 isPrimaryTopicOf JNJ-Q2.